🇺🇸 FDA
Patent

US 12343388

Clostridioides difficile TcdB variants, vaccines and methods of use

granted A61KA61K2039/52A61K2039/55544

Quick answer

US patent 12343388 (Clostridioides difficile TcdB variants, vaccines and methods of use) held by The Board of Regents of the University of Oklahoma expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/52, A61K2039/55544, A61K39/08, A61K47/02